{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:42:45Z","timestamp":1791286965146,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.autrev.2007.11.009","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T23:18:05Z","timestamp":1196983085000},"page":"164-167","source":"Crossref","is-referenced-by-count":51,"title":["Microvascular and microangiopathic antiphospholipid-associated syndromes (\u201cMAPS\u201d)"],"prefix":"10.1016","volume":"7","author":[{"given":"Ronald A.","family":"Asherson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2007.11.009_bib1","first-page":"1","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"3","author":"Miyakis","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2007.11.009_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/ard.2006.067033","article-title":"Is there a microangiopathic antiphospholipid syndrome?","volume":"66","author":"Asherson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.11.009_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.48.5.358","article-title":"Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the \u201cprimary\u201d antiphospholipid syndrome","volume":"48","author":"Asherson","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.11.009_bib4","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/ard.49.4.268-a","article-title":"Subungual splinter hemorrhages: a new sign of antiphospholipid coagulopathy?","volume":"49","author":"Asherson","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.11.009_bib5","first-page":"103","article-title":"Dermatological aspects of antiphospholipid antibody syndrome","volume":"vol. 5","author":"France","year":"2006"},{"key":"10.1016\/j.autrev.2007.11.009_bib6","first-page":"189","article-title":"Renal, hepatic and other intraabdominal manifestations in the antiphospholipid syndrome","volume":"vol. 11","author":"Von Landenberg","year":"2002"},{"key":"10.1016\/j.autrev.2007.11.009_bib7","first-page":"1742","article-title":"A \u201cprimary\u201d antiphospholipid syndrome?","volume":"15","author":"Asherson","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib8","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib9","first-page":"195","article-title":"The catastrophic antiphospholipid syndrome\u2014Asherson's syndrome","volume":"154","author":"Piette","year":"2003","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.autrev.2007.11.009_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","article-title":"Thrombotic microangiopathic haemolytic anemia (thrombotic microangiopathy)","volume":"ii","author":"Symmers","year":"1952","journal-title":"BMJ"},{"key":"10.1016\/j.autrev.2007.11.009_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.1962.tb06541.x","article-title":"Microangiopathic hemolytic anemia. The possible role of vascular lesions in pathogenesis","volume":"8","author":"Brain","year":"1962","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2007.11.009_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9343(99)00413-1","article-title":"Autoimmune hemolytic anemia in patients with systemic lupus erythematosus","volume":"108","author":"Kokori","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2007.11.009_bib13","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/art.21583","article-title":"Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: distinction from thrombotic thrombocytopenic purpura. Prognosis and outcome","volume":"6","author":"Dold","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.11.009_bib14","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2003.007245","article-title":"Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies","volume":"643","author":"Espinosa","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.11.009_bib15","article-title":"Relapsing Catastrophic Antiphospholipid Syndrome: Report of Three Cases","author":"Asherson","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.11.009_bib16","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10067-006-0487-8","article-title":"Severe limb necrosis: primary thrombotic microangiopathy or \u201cseronegative\u201d catastrophic antiphospholipid syndrome? A diagnostic dilemma","volume":"26","author":"Lazurova","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0049-0172(94)90073-6","article-title":"Systemic lupus erythematosus complicated by thrombotic microangiopathy","volume":"24","author":"Jain","year":"1991","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.11.009_bib18","first-page":"1916","article-title":"Thrombotic microangiopathy and the antiphospholipid antibody syndrome","volume":"18","author":"Durand","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib19","first-page":"1474","article-title":"Thrombotic thrombocytopenic purpura in systemic lupus erythematosus and antiphospholipid antibodies: effective treatment with plasma exchange and immunosuppression","volume":"19","author":"Hess","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0049-0172(94)90072-8","article-title":"Thrombotic microangiopathic anemia in systemic lupus erythematosus","volume":"24","author":"Nesher","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2007.11.009_bib21","first-page":"981","article-title":"Thrombotic thrombocytoenic purpura (TTP) observed in a patient with primary antiphospholipid antibody syndrome","volume":"34","author":"Umibe","year":"1994","journal-title":"Ryumachi"},{"key":"10.1016\/j.autrev.2007.11.009_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1034\/j.1600-0609.2000.9l125.x","article-title":"Fulminant thrombotic thrombocytopenic purpura in two patients with systemic lupus erythematosus and phospholipid autoantibodies","volume":"64","author":"Musa","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.autrev.2007.11.009_bib23","first-page":"795","article-title":"Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure","volume":"68","author":"Kincaid-Smith","year":"1988","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2007.11.009_bib24","first-page":"1360","article-title":"An association between refractory HELLP syndrome and antiphospholipid antibodies during pregnancy: a report of 2 cases","volume":"21","author":"Ornstein","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10067-007-0742-7","article-title":"The HELLP syndrome, antiphospholipid antibodies and syndromes","volume":"27","author":"Asherson","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/ncprheum0069","article-title":"Catastrophic antiphospholipid syndrome","volume":"2","author":"Merrill","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/17460816.1.3.355","article-title":"Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions?","volume":"1","author":"Asherson","year":"2006","journal-title":"Future Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib28","first-page":"195","article-title":"Bone marrow necrosis and refractory HELLP syndrome in a patient with catastrophic antiphospholipid antibody syndrome","volume":"29","author":"Sinha","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10067-004-1017-1","article-title":"Thrombotic microangiopathy with liver, gut and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome","volume":"2","author":"Koenig","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib30","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/ard.2004.026377","article-title":"Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and hematological characteristics of 23 patients","volume":"64","author":"Asherson","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2007.11.009_bib31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/ard.2006.067033","article-title":"Is there a microangiopathic antiphospholipid syndrome?","volume":"66","author":"Asherson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2007.11.009_bib32","first-page":"1793","article-title":"Microangiopathic antiphospholipid-associated syndromes revisited; new concepts relating to antiphospholipid antibodies and syndromes","volume":"34","author":"Asherson","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2007.11.009_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.autrev.2005.09.006","article-title":"Complement, natural antibodies, autoantibodies and tissue injury","author":"Fleming","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2007.11.009_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.autrev.2005.09.005","article-title":"The different faces of shared autoimmunity","author":"Rodriguez-Reyna","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2007.11.009_bib35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.autrev.2005.09.008","article-title":"Aging of the immune system: a risk factor for autoimmunity?","author":"Prelog","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2007.11.009_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.autrev.2005.08.001","article-title":"Primary antiphospholipid syndrome: a distinct entity?","author":"Mackworth-Young","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2007.11.009_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","article-title":"Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases","author":"Goules","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2007.11.009_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jaut.2006.09.001","article-title":"Autoantibody profiling to identify individuals at risk for systemic lupus erythematosus","author":"Wandstrat","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2007.11.009_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaut.2006.09.008","article-title":"Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients","author":"Kiss","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2007.11.009_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaut.2006.09.007","article-title":"Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI","author":"Iverson","year":"2006","journal-title":"J Autoimmun"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207001619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997207001619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T17:43:07Z","timestamp":1557078187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997207001619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1568997207001619"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2007.11.009","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}